Although both apCAFs in PDAC and apCAFs in certain solid tumor types such as HNSCC, CC, NPC, and RCC express MHC class II molecules like CD74, the potential transformation paths and enriched signaling pathways of these 2 apCAFs types greatly differ, possibly accounting for the pro-tumor effects of apCAFs in PDAC and the association of apCAFs with anti-tumor effects in certain solid tumor types like HNSCC, CC, NPC, and RCC. This evidence concerns the gene CD74 and nasopharyngeal carcinoma.